SPECIAL EMPHASIS PANELS
To view other meetings from ZCA1 choose calendar year:
| Study Section | Panel Name | Meeting Rosters |
|---|---|---|
| ZCA1 RTRB-S(J1) | SEP-10: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 10/24/23 |
| ZCA1 RTRB-U(J1) | CANCER IMMUNOPREVENTION NETWORK (CIP-NET) | 10/20/23 |
| ZCA1 SRB-2(J1) | PRIMARY CARE NEEDS OF CANCER SURVIVORS (U01) | 10/19/23 |
| ZCA1 TCRB-D(J1) | BIOSPECIMEN METHODS AND RESOURCES FOR CANCER RESEARCH | 10/19/23 |
| ZCA1 SRB-X(J2) | SEP-7: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 10/19/23 |
| ZCA1 SRB-1(J1) | NCI RESEARCH SPECIALIST AWARD (R50) CLINICAL | 10/19/23 |
| ZCA1 TCRB-J(J2) | SEP-8: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 10/18/23 |
| ZCA1 RPRB-M(J1) | NCI PROGRAM PROJECT (P01) REVIEW SEP- D | 10/18/23 |
| ZCA1 TCRB-5(C1) | SBIR CONCEPT AWARD | 10/18/23 |
| ZCA1 RPRB-T(J2) | NCI PANCREATIC CANCER DETECTION CONSORTIUM U01 | 10/17/23 |
| ZCA1 SRB-K(J2) | SEP-5: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 10/17/23 |
| ZCA1 SRB-A(J1) | SEP-4: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 10/17/23 |
| ZCA1 SRB-P(J2) | SEP-6: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 10/13/23 |
| ZCA1 SRB-F(J2) | SEP-3: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 10/12/23 |
| ZCA1 TCRB-J(J1) | CANCER PREVENTION AND CONTROL CLINICAL TRIALS | 10/11/23 |
| ZCA1 SRB-K(J1) | COLLABORATIVE HUMAN TISSUE NETWORK (CHTN) (UM1) | 10/11/23 |
| ZCA1 TCRB-O(J1) | SEP-9: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 10/11/23 |
| ZCA1 RPRB-H(J1) | NCI PROGRAM PROJECT (P01) REVIEW SEP- C | 10/11/23 |
| ZCA1 TCRB-V(J1) | CANCER EPIDEMIOLOGY COHORT STUDIES | 10/06/23 |
| ZCA1 SRB-X(J1) | NCI REVIEW OF APPLICATIONS TO RESEARCH PROJECTS IN PHYSICAL SCIENCES ONCOLOGY | 09/29/23 |
| ZCA1 RPRB-J(J1) | NCI PROGRAM PROJECT (P01) REVIEW SEP- B | 09/28/23 |
| ZCA1 TCRB-5(J1) | NCI INFORMATICS TECHNOLOGIES FOR CANCER RESEARCH I | 09/28/23 |
| ZCA1 SRB-2(J2) | SEP-1: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 09/28/23 |
| ZCA1 RPRB-8(J1) | NCI SPORE II | 09/28/23 |
| ZCA1 SRB-F(J1) | INTEGRATING HEALTH DISPARITIES INTO IMMUNO-ONCOLOGY (HDIO) | 09/27/23 |
| ZCA1 RPRB-6(J1) | NCI SPORE (P50) REVIEW I | 09/21/23 |
| ZCA1 RTRB-R(J1) | NCI TRANSITION CAREER DEVELOPMENT AWARD AND INSTITUTIONAL RESEARCH TRAINING GRANTS | 09/20/23 |
| ZCA1 RPRB-T(J1) | NCI PROGRAM PROJECT (P01) REVIEW SEP-A | 09/14/23 |
| ZCA1 RTRB-R(O2) | INSTITUTIONAL RESEARCH TRAINING GRANT | 08/16/23 |
| ZCA1 TCRB-Q(O2) | LIVER CANCER PROJECTS WITH THE CIRRHOSIS NETWORK | 08/04/23 |
| ZCA1 TCRB-O(O1) | U01 COLLABORATIVE RESEARCH SEP | 07/27/23 |
| ZCA1 TCRB-9(O2) | SEP-10: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 07/26/23 |
| ZCA1 RTRB-B(O1) | DIET, LIPID METABOLISM, AND CANCER | 07/19/23 |
| ZCA1 RPRB-L(O1) | NCI PROGRAM PROJECT (P01) REVIEW SEP- E | 07/19/23 |
| ZCA1 PCRB-9(O1) | R13 CONFERENCE GRANT REVIEW | 07/18/23 |
| ZCA1 RTRB-Z(O1) | STIMULATING ACCESS TO RESEARCH IN RESIDENCY (R38) | 07/12/23 |
| ZCA1 TCRB-D(O1) | MOLECULAR AND CELLULAR ANALYSIS TECHNOLOGIES | 07/06/23 |
| ZCA1 RPRB-H(A1) | NCI U01 AND U24 REVIEW: PRECOMPETITIVE COLLABORATION ON LIQUID BIOPSY FOR EARLY CANCER ASSESSMENT | 06/29/23 |
| ZCA1 SRB-1(O2) | SEP-2: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 06/29/23 |
| ZCA1 RPRB-M(O2) | NCI RESEARCH PROJECT-COOPERATIVE AGREEMENTS (U01) | 06/28/23 |
| ZCA1 SRB-P(O1) | NCI CANCER SCREENING RESEARCH NETWORK: CLINICAL RESEARCH COOPERATIVE AGREEMENTS (UG1 CLINICAL TRIAL REQUIRED) | 06/27/23 |
| ZCA1 RTRB-S(O1) | SEP-9: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 06/27/23 |
| ZCA1 TCRB-Q(O1) | ADVANCED DEVELOPMENT OF ANALYSIS TECHNOLOGIES | 06/23/23 |
| ZCA1 RTRB-U(O1) | NCI PATHWAY TO INDEPENDENCE AWARD FOR OUTSTANDING EARLY-STAGE POSTDOCTORAL RESEARCHERS | 06/22/23 |
| ZCA1 TCRB-V(O1) | SEP-8: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 06/22/23 |
| ZCA1 SRB-K(O1) | SEP-5: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 06/21/23 |
| ZCA1 SRB-2(A1) | BUILDING COLLABORATIVE PARTNERSHIPS AND ADVANCING CANCER HEALTH EQUITY | 06/21/23 |
| ZCA1 SRB-F(O1) | SEP-3: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 06/21/23 |
| ZCA1 RPRB-M(O1) | NCI PROGRAM PROJECT (P01) SEP-D | 06/20/23 |
| ZCA1 SRB-1(O1) | NCI RESEARCH SPECIALIST AWARD (CLINICIAN) | 06/20/23 |
| ZCA1 TCRB-5(O2) | IMAT BIOSPECIMEN RESEARCH | 06/16/23 |
| ZCA1 SRB-P(O2) | SEP-6: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 06/13/23 |
| ZCA1 RPRB-J(O1) | NCI PROGRAM PROJECT (P01) SEP-B | 06/12/23 |
| ZCA1 SRB-2(O2) | SEP-1: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 06/08/23 |
| ZCA1 RPRB-8(O2) | “ASSAY VALIDATION OF HIGH QUALITY MARKERS FOR CLINICAL STUDIES IN CANCER” (UH2/3) | 06/08/23 |
| ZCA1 RPRB-T(O1) | NCI PROGRAM PROJECT (P01) SEP-C | 06/08/23 |
| ZCA1 RPRB-6(A1) | NCI R01/R34 ADVANCING ADOLESCENT TOBACCO CESSATION INTERVENTION REVIEW MEETING | 06/02/23 |
| ZCA1 TCRB-9(O1) | CANCER PREVENTION AND CONTROL CLINICAL TRIALS | 06/01/23 |
| ZCA1 TCRB-D(C2) | PREVENT TEP 2 | 05/26/23 |
| ZCA1 SRB-X(O1) | SEP-7: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 05/25/23 |
| ZCA1 RPRB-6(O1) | NCI PROGRAM PROJECT (P01) SEP-A | 05/25/23 |
| ZCA1 RTRB-R(O1) | NCI TRANSITION CAREER DEVELOPMENT AWARD AND INSTITUTIONAL RESEARCH TRAINING GRANTS | 05/25/23 |
| ZCA1 TCRB-V(A1) | CANNABIS USE DURING TREATMENT | 05/25/23 |
| ZCA1 RPRB-H(O1) | NCI SPORE (P50) REVIEW SEP-II | 05/24/23 |
| ZCA1 TCRB-D(C1) | PREVENT TEP 1 | 05/24/23 |
| ZCA1 TCRB-J(C1) | PREVENT TEP 3 | 05/23/23 |
| ZCA1 SRB-A(O1) | SEP-4: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 05/23/23 |
| ZCA1 RPRB-8(O1) | NCI SPORE (P50) REVIEW SEP-I | 05/18/23 |
| ZCA1 TCRB-5(O1) | CANCER EPIDEMIOLOGY COHORT STUDIES | 05/18/23 |
| ZCA1 RTRB-F(M1) | CANCER CENTER SUPPORT GRANT | 05/12/23 |
| ZCA1 TCRB-J(O1) | INTEGRATING BIOSPECIMEN SCIENCE APPROACHES | 05/11/23 |
| ZCA1 GRB-I(C1) | FFRDC REVIEW MEETING | 05/04/23 |
| ZCA1 RPRB-J(M2) | SEP-6: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 04/07/23 |
| ZCA1 TCRB-Q(M2) | ADVANCED DEVELOPMENT OF INFORMATICS TECHNOLOGIES FOR CANCER RESEARCH | 03/31/23 |
| ZCA1 RTRB-C(M1) | SEP-1: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 03/29/23 |
| ZCA1 SRB-P(M2) | SEP-7: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 03/29/23 |
| ZCA1 RTRB-B(M1) | SEP-8: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 03/29/23 |
| ZCA1 TCRB-9(C1) | TEP-5: SBIR CONTRACT REVIEW | 03/28/23 |
| ZCA1 RTRB-F(M2) | RESEARCH CENTERS FOR CANCER SYSTEMS BIOLOGY | 03/27/23 |
| ZCA1 RTRB-4(M1) | METASTASIS RESEARCH NETWORK (U01) | 03/24/23 |
| ZCA1 TCRB-D(M1) | EBV INFECTIONS AND CANCER HEALTH DISPARITIES | 03/23/23 |
| ZCA1 RPRB-L(M2) | SEP-3: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 03/23/23 |
| ZCA1 RPRB-M(M1) | NCI K38 REVIEW MEETING | 03/22/23 |
| ZCA1 RPRB-H(M2) | SEP-9: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 03/22/23 |
| ZCA1 TCRB-Q(C1) | TEP-4: SBIR CONTRACT REVIEW MEETING | 03/17/23 |
| ZCA1 RPRB-T(M1) | SEP-4: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 03/15/23 |
| ZCA1 SRB-K(M3) | CANCER PREVENTION-INTERCEPTION TARGETED AGENT DISCOVERY PROGRAM (CAP-IT) CENTERS (U54) | 03/14/23 |
| ZCA1 SRB-1(M2) | NCI RESEARCH SPECIALIST (CLINICAL SCIENTIST) AWARD (R50) | 03/10/23 |
| ZCA1 TCRB-V(C1) | TEP-2: SBIR CONTRACT REVIEW | 03/09/23 |
| ZCA1 TCRB-9(M2) | INFORMATICS METHOD FOR CANCER RESEARCH | 03/09/23 |
| ZCA1 SRB-F(M3) | CLINICAL SITES FOR THE HIV/CERVICAL CANCER PREVENTION 'CASCADE' CLINICAL TRIALS NETWORK | 03/09/23 |
| ZCA1 TCRB-J(C1) | TEP-1: SBIR CONTRACT REVIEW: DEVELOPMENT OF SENOTHERAPEUTIC AGENTS FOR CANCER TREATMENT | 03/08/23 |
| ZCA1 SRB-2(M2) | GLOBAL IMPLEMENTATION SCIENCE FOR EQUITABLE CANCER CONTROL | 03/08/23 |
| ZCA1 SRB-P(M1) | CANCER TARGET DISCOVERY AND DEVELOPMENT NETWORK, CTD2 (U01) | 03/07/23 |
| ZCA1 TCRB-O(C1) | TEP-6: SBIR CONTRACT REVIEW | 03/07/23 |
| ZCA1 PCRB-9(M1) | R13 CONFERENCE GRANT REVIEW | 03/07/23 |
| ZCA1 SRB-A(M2) | SEP-2: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 03/03/23 |
| ZCA1 SRB-1(M1) | NCI RESEARCH SPECIALIST AWARD (R50) | 03/02/23 |
| ZCA1 RTRB-Y(M1) | CANCER ADOPTIVE CELLULAR THERAPY NETWORK (CAN-ACT) | 03/02/23 |
| ZCA1 RPRB-J(M1) | NCI PROGRAM PROJECT (P01) SEP-A | 03/02/23 |
| ZCA1 RTRB-U(M1) | PATIENT DERIVED XENOGRAFT (PDX) DEVELOPMENT AND TRIAL CENTERS (PDTCS) NETWORK (U54 AND U24) | 03/02/23 |
| ZCA1 TCRB-D(C1) | TEP-7: SBIR CONTRACT REVIEW | 03/02/23 |
| ZCA1 SRB-X(M2) | REVIEW OF RESEARCH PROJECTS (U01) IN PHYSICAL SCIENCES- ONCOLOGY | 03/01/23 |
| ZCA1 RPRB-6(M2) | NCI CANCER MOONSHOT SCHOLARS DIVERSITY PROGRAM R01 MEETING | 03/01/23 |
| ZCA1 SRB-K(M2) | SEP-5: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 02/27/23 |
| ZCA1 TCRB-5(C1) | TEP-3: SBIR CONTRACT REVIEW MEETING | 02/24/23 |
| ZCA1 SRB-E(M1) | NCI OUTSTANDING INVESTIGATOR AWARD (R35) | 02/23/23 |
| ZCA1 TCRB-Q(M1) | TRANSLATIONAL RESEARCH CENTERS FOR EARLY DETECTION OF LIVER CANCER. | 02/23/23 |
| ZCA1 RPRB-N(M1) | NCI SPORE (P50) REVIEW IV | 02/23/23 |
| ZCA1 RPRB-7(M1) | NCI PREDOC TO POSTDOC FELLOW TRANSITION AWARD (F99/K00) | 02/21/23 |
| ZCA1 RPRB-L(M1) | NCI PROGRAM PROJECT (P01) REVIEW SEP-B | 02/21/23 |
| ZCA1 TCRB-V(M2) | CLINICAL TRIALS PLANNING PROGRAM | 02/17/23 |
| ZCA1 RPRB-8(M2) | NCI PANCREATIC CANCER DETECTION CONSORTIUM U01 | 02/16/23 |
| ZCA1 SRB-K(M1) | CANCER IMMUNE MONITORING AND ANALYSIS CENTERS REVIEW (U24) | 02/15/23 |
| ZCA1 SRB-F(M1) | SEP-C: NCI PROGRAM PROJECT (P01) | 02/15/23 |
| ZCA1 RPRB-H(M1) | NCI SPORE (P50) REVIEW III | 02/15/23 |
| ZCA1 TCRB-9(M1) | BIOSPECIMEN SCIENCE AND USE OF PLCO BIOSPECIMENS | 02/14/23 |
| ZCA1 SRB-A(M1) | NCI-PEDIATRIC IMMUNOTHERAPY NETWORK (PIN) | 02/14/23 |
| ZCA1 TCRB-3(C2) | TEP 8B: SBIR REVIEW MEETING | 02/02/23 |
| ZCA1 RPRB-8(M1) | NCI SPORE (P50) REVIEW II | 02/02/23 |
| ZCA1 TCRB-J(M2) | DEVELOPMENT OF INFORMATICS TECHNOLOGIES FOR CANCER RESEARCH AND MANAGEMENT | 02/02/23 |
| ZCA1 TCRB-3(C1) | TEP 8A: CONTRACT REVIEW MEETING | 02/01/23 |
| ZCA1 TCRB-J(M1) | INTEGRATING BIOSPECIMEN SCIENCE APPROACHES INTO CLINICAL ASSAY DEVELOPMENT | 02/01/23 |
| ZCA1 RPRB-6(M1) | NCI SPORE (P50) REVIEW I | 01/31/23 |
| ZCA1 SRB-X(M1) | RADIATION ONCOLOGY-BIOLOGY INTEGRATION NETWORK (ROBIN) CENTERS REVIEW | 01/27/23 |
| ZCA1 RTRB-R(M1) | NCI TRANSITION CAREER DEVELOPMENT AWARD AND INSTITUTIONAL RESEARCH TRAINING GRANTS | 01/26/23 |
| ZCA1 TCRB-5(M1) | INNOVATIVE MOLECULAR ANALYSIS TECHNOLOGIES (IMAT) | 01/26/23 |
| ZCA1 TCRB-V(M1) | ASSAY VALIDATION OF BIOMARKERS | 01/25/23 |
| ZCA1 SRB-2(M1) | SURVIVORSHIP NEEDS OF INDIVIDUALS WITH ADVANCED CANCER | 01/12/23 |